argus

Indoco Remedies Ltd.

NSE: INDOCOINE873D010242,244 Cr

Timeline

Time (IST)TypeMEventSrc
09 Feb, 05:58 pmIndoco Remedies Limited has informed the Exchange about Transcriptnse
09 Feb, 05:55 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
09 Feb, 05:37 pmIndoco Remedies Limited has informed the Exchange about Conclusion of Search by GST Authoritiesnse
09 Feb, 05:34 pmIndoco Remedies Ltd - 532612 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
03 Feb, 06:47 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
03 Feb, 06:40 pmIndoco Remedies Limited has informed the Exchange about Link of Recordingnse
03 Feb, 12:04 pmIndoco Remedies Ltd - 532612 - Financial Results For The Quarter And Nine Months Ended 31St December, 2025bse
03 Feb, 12:00 pmIndoco Remedies Ltd - 532612 - Board Meeting Outcome for Outcome Of Board Meeting Held On 03/02/2026bse
03 Feb, 11:59 amIndoco Remedies Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
03 Feb, 11:16 amIndoco Remedies Limited has informed the Exchange about Intimation of visiting of GST authorities for searchnse
03 Feb, 11:13 amIndoco Remedies Ltd - 532612 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
30 Jan, 01:23 pmIndoco Remedies Limited has informed the Exchange regarding a press release dated January 30, 2026, titled "Indoco Remedies receives final ANDA approval from USFDA for Lacosamide Oral Solution USP,10mg/mL".nse
30 Jan, 01:14 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
16 Jan, 05:32 pmIndoco Remedies Ltd - 532612 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
13 Jan, 05:26 pmIndoco Remedies Ltd - 532612 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011bse
31 Dec, 10:36 amIndoco Remedies Ltd - 532612 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011bse
31 Dec, 10:35 amIndoco Remedies Ltd - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
30 Dec, 05:32 pmKare Family Private Trust has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011nse
19 Dec, 10:24 amIndoco Remedies Ltd - 532612 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011bse
18 Dec, 12:37 pmAditi Milind Panandikar has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
15 Dec, 06:20 pmIndoco Remedies Ltd - 532612 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011bse
11 Dec, 05:47 pmIndoco Remedies Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga ".nse
11 Dec, 05:44 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
01 Dec, 10:44 amAditi Milind Panandikar has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.nse
28 Nov, 06:56 pmAditi Milind Panandikar has submitted to the Exchange a copy of Disclosures under Regulation 10(6) Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011nse
28 Nov, 04:34 pmIndoco Remedies Limited has informed the Exchange about Retirement of Senior Management Personalnse
28 Nov, 01:49 pmIndoco Remedies Ltd - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
18 Nov, 12:49 pmIndoco Remedies Ltd - 532612 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011bse
18 Nov, 11:54 amAditi M Panandikar has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
10 Nov, 02:30 pmIndoco Remedies Limited has informed the Exchange about Transcriptnse
10 Nov, 02:22 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
06 Nov, 07:35 pmIndoco Remedies Limited has informed the Exchange about Link of Recordingnse
06 Nov, 07:30 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
06 Nov, 11:44 amIndoco Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
06 Nov, 11:37 amIndoco Remedies Ltd - 532612 - Financial Results For The Quarter And Half Year Ended 30Th September, 2025bse
06 Nov, 11:33 amIndoco Remedies Ltd - 532612 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th November, 2025bse
29 Oct, 11:06 amIndoco Remedies Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (LODR) Regulations,2015 - Corporate Gurantee for Warren Remedies Pvt Ltd , wholly owned subsidiary of the Company.nse
18 Oct, 12:37 pmIndoco Remedies Limited has informed the Exchange about 100 Days Campaign Saksham Niveshaknse
14 Oct, 01:58 pmIndoco Remedies Ltd - 532612 - Clarification To BSE- Movement In Volumebse
14 Oct, 11:27 amIndoco Remedies Ltd - 532612 - Clarification sought from Indoco Remedies Ltdbse
14 Oct, 11:21 amIndoco Remedies Ltd - 532612 - Board Meeting Intimation for Intimation Of Board Meeting Under Reg 29 Of SEBI (LODR) Regulations 2015bse
14 Oct, 11:02 amSignificant increase in volume has been observed in Indoco Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Indoco Remedies Limited has submitted their response.nse
13 Oct, 06:26 pmSignificant increase in volume has been observed in Indoco Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
25 Sept, 12:05 pmIndoco Remedies Limited has informed the Exchange about Credit Ratingnse
25 Sept, 11:55 amIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
19 Sept, 02:38 pmIndoco Remedies Limited has informed the Exchange regarding a press release dated September 19, 2025, titled "USFDA successfully completes inspection at Indoco s API manufacturing facility at Patalganga with zero observations".nse
19 Sept, 02:36 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 Sept, 11:34 amSignificant increase in volume has been observed in Indoco Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Indoco Remedies Limited has submitted their response.nse
11 Sept, 06:55 pmSignificant increase in volume has been observed in Indoco Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse